MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Insurance & Technology
June 4, 2009
Anthony O'Donnell
Patni Introduces Claims-as-a-Service (CaaS) for Health Insurers The solution combines Patni's ITO and BPO services with by TriZetto's QNXT core administration platform. mark for My Articles similar articles
Insurance & Technology
August 10, 2006
Alliances & Partnerships PlanView has embedded Business Objects' XI Release 2 into the PlanView Enterprise portfolio management platform... Eagle Investment Systems, a Mellon Financial company, and Patni Computer Systems have partnered... etc. mark for My Articles similar articles
Bank Systems & Technology
September 2, 2010
Katherine Burger
Paul Johnson of BB&T: Transformation Never Ends Nearing completion of a program to overhaul the way his technology organization operates and how it is viewed by the business, BB&T EVP and CIO Paul Johnson says the evolution of IT is an ongoing journey. mark for My Articles similar articles
The Motley Fool
June 4, 2010
Brian Orelli
Out With Drugs, in With Medical Devices Johnson & Johnson's movement in medical devices and diagnostics is headed in the right direction, but whether Johnson & Johnson is a buy depends a lot on how it handles its current drug problem. Unfortunately investors can't have one without the other. mark for My Articles similar articles
The Motley Fool
June 28, 2011
Eric Bleeker
Johnson & Johnson Is Looking Abroad for Growth Where's Johnson & Johnson generating its sales? mark for My Articles similar articles
The Motley Fool
July 12, 2011
Todd Wenning
What Does Johnson & Johnson Do With Its Free Cash? Johnson & Johnson appears to be making fair use of its free cash flow, and its well-covered dividend may be attractive to income-focused investors. mark for My Articles similar articles
The Motley Fool
June 23, 2010
Brian Orelli
Duo of Diabetes Drug Deals Make J&J Better Licensing deals add to Johnson & Johnson's diabetes franchise. mark for My Articles similar articles
The Motley Fool
May 22, 2009
Brian Orelli
J&J and Cougar: Meow or Roar? Health-care giant Johnson & Johnson is doing something that many of its investors -- Buffett included -- wouldn't do; it's buying a development-stage drugmaker that has no proven drugs. mark for My Articles similar articles
The Motley Fool
October 6, 2009
Jennifer Schonberger
This Is How We Should Fix the Financial System Economist Simon Johnson says a decision about regulating derivatives was the defining event. mark for My Articles similar articles
The Motley Fool
July 31, 2007
Nathan Parmelee
Break Out the Band-Aids at J&J Johnson & Johnson is making some deep cuts to change its cost structure. Shareholders haven't had much to cheer about lately here, but the potential benefits from this move could help cure some of the current softness in the business. mark for My Articles similar articles
Fast Company
November 2015
Max Chafkin
How Failed JC Penney CEO Ron Johnson Is Redeeming Himself With Enjoy The company sells consumer electronics via the web and has its couriers, or "Experts," in Johnson's parlance, act as modern-day Maytag Men, hand-delivering the items in as little as four hours. mark for My Articles similar articles
The Motley Fool
July 14, 2008
Brian Orelli
Foolish Forecast: J&J Trudges Along In advance of earnings analysts wonder if Johnson & Johnson is a recovery story waiting to happen, or still stuck in a rut? mark for My Articles similar articles